B013
SPH-B013-201
Phase 2 small_molecule active
Quick answer
B013 for Platinum-resistant Recurrent Ovarian Cancer is a Phase 2 program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BRIGHT MINDS BIOSCIENCES INC.
- Indication
- Platinum-resistant Recurrent Ovarian Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active